Gamma-Glutamyl Transferase: Another Biomarker for Metabolic Syndrome and Cardiovascular Risk

Arteriosclerosis, Thrombosis, and Vascular Biology - United States
doi 10.1161/01.atv.0000253905.13219.4b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Gamma Glutamyl Transferase and Metabolic Syndrome, Cardiovascular Disease, and Mortality Risk: The Framingham Heart Study

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2007English

Gamma-Glutamyl Transferase in Duodenum Tissues of Infant Rabbits

Vestnik of Ulyanovsk State Agricultural Academy
2016English

Serum Gamma-Glutamyl Transferase Activity in Volunteer Blood Donors.

Journal of Clinical Pathology
MedicineForensic MedicinePathology
1977English

Osteocalcin as a Potential Risk Biomarker for Cardiovascular and Metabolic Diseases

Clinical Chemistry and Laboratory Medicine
BiochemistryMedicineClinical Biochemistry
2016English

Novel Cardiovascular Risk Biomarkers in Metabolic Syndrome

Biomarkers in Medicine
BiochemistryDrug DiscoveryClinical Biochemistry
2019English

Metabolic Syndrome and Risk Factors for Cardiovascular Disease: Are Nonagenarians Protected?

AGE
2009English

Serum -Glutamyl Transferase and Risk of Heart Failure in the Community

Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular MedicineCardiology
2010English

Central Versus Peripheral Cardiovascular Risk in Metabolic Syndrome

Frontiers in Physiology
Physiology
2012English

The Predictive Value of Gamma-Glutamyl Transferase in Acute Myocardial Infarction and Ischemic Stroke

The Journal of Tepecik Education and Research Hospital
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy